-
Why Cathie Wood Favorite Ginkgo Bioworks Is Surging After Hours
Monday, August 15, 2022 - 4:49pm | 383Read More...Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher in Monday's after-hours session after the company reported strong financial results and raised full-year guidance above analyst estimates. Ginkgo Bioworks said second-quarter revenue jumped 231% year-over-year to...
-
Cronos Group And Ginkgo Bioworks Achieve Rare Cannabinoid THCV Equity Milestone
Tuesday, June 21, 2022 - 7:31am | 346Read More...Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) and Ginkgo Bioworks (NYSE: DNA) achieved the third target productivity milestone in their partnership to produce eight cultured cannabinoids. Using Ginkgo's platform for organism design and development, Cronos has successfully achieved the...
-
Cronos Group, Ginkgo Bioworks Modify Agreement To Speed Up Commercialization of Cultured Cannabinoids
Friday, June 4, 2021 - 1:50pm | 382Read More...Cannabinoid company Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is amending its previous partnership agreement with Ginkgo Bioworks, Inc., a company involved in cell programming. The amendment allows Cronos to start commercializing products with cultured cannabinoids before...
